San Diego, CA, United States of America

Patria E Danielson


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Celebrating the Innovations of Patria E. Danielson

Introduction: Patria E. Danielson, a pioneering inventor based in San Diego, CA, has made significant contributions to the field of neuroscience through her unique patent. With a focus on understanding and manipulating the hypothalamus-related processes, her inventions are paving the way for advancements in therapeutic treatments.

Latest Patents: Patria holds a patent for "Hypothalamus-specific polypeptides." This patent encompasses hypocretin polynucleotides and hypocretin polypeptides, alongside antibodies, oligonucleotides, diagnostic kits and methods, as well as therapeutic compositions and methods. Hypocretin, a novel hypothalamic-specific polypeptide identified, is localized in regions of the hypothalamus that are crucial for appetite and feeding behavior. The biological activity of hypocretin polypeptides can result in electrical changes in neurons, lower body temperature, and reduced food intake, showcasing the potential impact of her work on obesity and appetite regulation.

Career Highlights: Patria E. Danielson is affiliated with The Scripps Research Institute, where she engages in cutting-edge research and innovation. Her dedication to scientific discovery has enabled her to make notable advances in understanding the role of hypocretin in human physiology.

Collaborations: Throughout her career, Danielson has collaborated with esteemed colleagues, including J. Gregor Sutcliffe and Kaare M. Gautvik. These partnerships emphasize the importance of teamwork in the pursuit of scientific breakthroughs and highlight the collective effort found within research institutions.

Conclusion: Patria E. Danielson stands out as an inspiring inventor whose contributions to the field of neuroscience are paving the way for future advancements. Her innovative work with hypothalamus-specific polypeptides has significant implications for therapeutic applications. As she continues her journey in research at The Scripps Research Institute, her future inventions will undoubtedly further our understanding of appetite and feeding behaviors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…